Rankings
▼
Calendar
TECX
Tectonic Therapeutic, Inc.
$635M
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$354,000
Operating Income
-$28M
Net Income
-$28M
EPS (Diluted)
$-7.70
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$29M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$146M
Total Liabilities
$28M
Stockholders' Equity
$118M
Cash & Equivalents
$132M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$354,000
-$299,000
-18.4%
Operating Income
-$28M
-$31M
+11.5%
Net Income
-$28M
-$31M
+10.6%
← FY 2022
All Quarters
Q3 2022 →
TECX Q2 2022 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena